Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women

References

• Spady T J, McComb R D, Shull J D. Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland. Endocrine 1999; 11: 217–233
   PubMedGoogle Scholar
• Rossouw J E, Anderson G L, Prentice R L, Lacroix A Z, Kooperberg C, Stefanick M L, Jackson R, Beresford S AA, Howard B, Johnson K C, Kotchen J M, , Writing Group for the Women's Health Initiative Investigators, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Oliveira M C, Moraes J T, Barros H TM, Barbosa-Coutinho L M. Effect of estrogen and neuroleptics on prolactin secretion and immunoreactive prolactin cells. Braz J Med Biol Res 1996; 29: 521–525
   PubMedGoogle Scholar
• Asa S L, Kelly M A, Grandy D K, Low M J. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 1999; 140: 5348–5355
   PubMedGoogle Scholar
• Scheithauer B W, Sano T, Kovacs K, Young W F, Ryan N, Randall R V. The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990; 65: 461–474
   PubMed Web of Science ®Google Scholar
• Pressman B D. Pituitary imaging. The pituitary. 2nd ed., S Melmed. Blackwell Science, Massachusetts 2002; 663–686
   Google Scholar
• Hentges S, Sarkar D K. Transforming growth factor-β regulation of estradiol-induced prolactinomas. Front Neuroendocrinol 2001; 22: 340–363
   PubMedGoogle Scholar
• Susuki M, Takashima T, Kadoya M, Konishi H, Kameyama T, Yoshikawa J, Gabata T, Arai K, Tamura S, Yamamoto T, et al. Height of normal pituitary gland on MR imaging: age and sex differentiation. J Comput Assist Tomogr 1990; 14: 36–39
   PubMedGoogle Scholar
• Lurie S N, Doraiswamy P M, Husain M M, Boyko O B, Ellinwood E H, Figiel G S, Krishnan K RR. In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J Clin Endocrinol Metab 1990; 71: 505–508
   PubMedGoogle Scholar
• Tsunoda A, Okuda O, Sato K. MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and climacterium. AJNR Am J Neuroradiol 1997; 18: 551–554
   PubMed Web of Science ®Google Scholar
• Reyes F I, Winter J SD, Faiman C. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 1977; 129: 557–564
   PubMed Web of Science ®Google Scholar
• Balint-Peric L A, Prelevic G M. Changes in prolactin levels with the menopause: the effects of estrogen/androgen and calcitonin treatment. Gynecol Endocrinol 1997; 11: 275–280
   PubMed Web of Science ®Google Scholar
• Katznelson L, Riskind P N, Saxe V C, Klibanski A. Prolactin pulsatile characteristics in postmenopausal women. J Clin Endocrinol Metab 1998; 83: 761–764
   PubMedGoogle Scholar
• Urban R J. Neuroendocrinology of aging in the male and female. Endocrinol Metab Clin North Am 1992; 21: 921–931
   PubMed Web of Science ®Google Scholar
• Karunakaran S, Page R C, Wass J A. The effect of the menopause on prolactin levels in patients with hyperprolactinemia. Clin Endocrinol (Oxf) 2001; 54: 295–300
   PubMed Web of Science ®Google Scholar
• Desai M P, Mehta R U, Choksi C S, Colaco M P. Pituitary enlargement on magnetic resonance imaging in congenital hypothyroidism. Arch Pediatr Adolesc Med 1996; 150: 623–628
   PubMedGoogle Scholar
• Arafah B M. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001; 344: 1784–1785
   PubMedGoogle Scholar
• Cano A, Martínez M, Benito P, Tofé S, Higuera A, Muñoz R. Analysis of indirect signs of microprolactinoma at MR imaging. Eur J Radiol 1997; 31: 157–164
   Google Scholar
• Asscheman H, Gooren L JG, Assies J, Smits J PH, De Slegte R. Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals. Clin Endocrinol (Oxf) 1988; 28: 583–588
   PubMed Web of Science ®Google Scholar
• Scheithauer B W, Kovacs K T, Randall R, Ryan N. Effects of estrogen on the human pituitary: a clinicopathologic study. Mayo Clin Proc 1989; 64: 1077–1084
   PubMedGoogle Scholar
• Bevan J S, Sussman J, Roberts A, Hourihan M, Peters J R. Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Case report. Br J Obstet Gynaecol 1989; 96: 1440–1444
   PubMedGoogle Scholar
• Oliveira M C, Spritzer P, Poy M, Coronel A X, Dahlem N, Moraes J T, Barbosa-Coutinho L M. Progestin effects on prolactin secretion and on immunoreactive prolactin cells in estradiol-treated ovariectomized rats. Horm Metab Res 1993; 25: 600–602
   PubMedGoogle Scholar